http://rdf.ncbi.nlm.nih.gov/pubchem/reference/35210093

Outgoing Links

Predicate Object
contentType Journal Article
issn 2234-943X
pageRange 1084683-
publicationName Frontiers in Oncology
startingPage 1084683
hasFundingAgency http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_487baf6554eb36bb22c6138d90a7c50f
bibliographicCitation Chen Q, Han X, Zheng G, Yang Y, Li Y, Zhang E, Yang L, Dong M, He D, He J, Cai Z. The adverse impact of a gain in chromosome 1q on the prognosis of multiple myeloma treated with bortezomib-based regimens: A retrospective single-center study in China. Front Oncol. 2022;12():1084683. PMID: 36605445; PMCID: PMC9808074.
creator http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_48e921b3cd7026d7597df3c897112cc7
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_60314c9376bf62fdc9cbd67dda6da1df
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_c7fe8d63e34f62acb59474bfd17a7b14
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_fd53b22f4b15280ce253d7fecb6b1e6c
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_044d835cfab7e78080707ed70f1e38d0
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_f691c1d660891c299779a7fc37a71af3
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_645bd5c7c983695f685c121707d165d3
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_e96c16370fca65000fbc2b124c382fe8
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_6f68f90b4dbb423db42f3898167597aa
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_bf1afdbcea850e6c2954a1f47febe590
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_8ff2d569a67ba5b648eca9ddaffbc316
date 2022-12-20-04:00^^<http://www.w3.org/2001/XMLSchema#date>
identifier https://pubmed.ncbi.nlm.nih.gov/PMC9808074
https://pubmed.ncbi.nlm.nih.gov/36605445
https://doi.org/10.3389/fonc.2022.1084683
isPartOf http://rdf.ncbi.nlm.nih.gov/pubchem/journal/39509
https://portal.issn.org/resource/ISSN/2234-943X
language English
source https://pubmed.ncbi.nlm.nih.gov/
https://www.crossref.org/
title The adverse impact of a gain in chromosome 1q on the prognosis of multiple myeloma treated with bortezomib-based regimens: A retrospective single-center study in China
discussesAsDerivedByTextMining http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_25c39b14f5f5fb71c1e3563d0a89b452
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7277
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID387447
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8530
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8561
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8607
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_1bf450fbc4b935abf2ef1f826f3802bd
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_73717aafac1e7701dab0fa02b8936926

Total number of triples: 36.